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Abstract
Background—The lethal thrombocytopenia that accompanies liver xenotransplantation is a 
barrier to clinical application. Human platelets are bound by the asialoglycoprotein receptor 
(ASGR) on pig sinusoidal endothelial cells and phagocytosed. Inactivation of the ASGR1 gene in 
donor pigs may prevent xenotransplantation-induced thrombocytopenia.
Methods—Transcription activator-like effector nucleases (TALENs) were targeted to the ASGR1 
gene in pig liver derived cells. ASGR1 deficient pig cells were used for somatic cell nuclear 
transfer (SCNT). ASGR1 knock out (ASGR1−/−) fetal fibroblasts were used to produce healthy 
ASGR1 knock out piglets. Human platelet uptake was measured in ASGR1 and ASGR1−/− livers.
Results—Targeted disruption of the ASGR1 gene with TALENs eliminated expression of the 
receptor. ASGR1−/− livers phagocytosed fewer human platelets than domestic porcine livers 
during perfusion.
Conclusions—The use of TALENs in liver-derived cells followed by SCNT enabled the 
production of healthy homozygous ASGR1 knock out pigs. Livers from ASGR1−/− pigs exhibit 
decreased human platelet uptake. Deletion of the ASGR1 gene is a viable strategy to diminish 
platelet destruction in pig-to-human xenotransplantation.
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INTRODUCTION
Xenotransplantation using pig organs could allow end-stage liver disease patients to receive 
a transplant, but a lethal thrombocytopenia that occurs shortly following graft reperfusion 
prevents clinical application [1, 2]. Pig liver sinusoidal endothelial cells (LSEC) and Kupffer 
cells (KC) remove human platelets from the circulation by endocytosis [3–5]. In vitro data 
shows that the mechanism of human platelet removal is partially dependent upon the 
asialoglycoprotein receptor (ASGR) (Figure 1), and the glycosylation pattern of pig and 
human platelets [4–6]. ASGR binds glycoproteins lacking terminal sialic acids and clears 
them from the circulation via receptor-mediated endocytosis [7, 8]. ASGR has roles in 
clearing prothrombotic blood components, platelets, von Willebrand factor (VWF), and 
factor VIII from the circulation [8, 9]. It also plays a critical role in the removal of cold 
stored platelets, limiting the shelf life of banked platelets for transfusion to a few days [10]. 
In murine models of streptococcal sepsis ASGR plays an important role in desialylated 
platelet clearance, preventing fatal thrombosis [11], and ASGR may be responsible for the 
clearance of lipoproteins and chylomicrons in a mechanism distinct from the LDL receptor 
pathway.
The functional heterotrimeric ASGR receptor, consisting of one ASGR2 and two ASGR1 
subunits, is expressed in liver and can be disrupted by elimination of the ASGR1 protein 
[12]. We used TALENs targeted to the ASGR1 gene to create pigs lacking expression of the 
ASGR1 protein. Liver from these animals were evaluated for platelet uptake in an ex vivo 
perfusion model.
MATERIALS AND METHODS
Design of TALENS
Custom TALEN plasmids were designed to bind and cleave the region containing the start 
codon ATG in exon 2 of ASGR1. The design, cloning, and validation of the TALENs were 
performed by Cellectis as previously described [13]. The full binding site of the TALEN pair 
used is: 5’-TTCGAGGTCTAGCCAGCcttagcatgacaaagGAATATCAGGATCTGCA-3’, 
where the underlined letters are the TALEN binding sites and the lowercase letters are where 
the double-strand break was created.
Cell Culture and Transfection of Liver-Derived Cells (LDC)
Porcine adult LDC were isolated as previously described [14] and cultured in a combination 
media SCM (a-MEM:EGM-MV 3:1) (Invitrogen/Lonza, Switzerland) supplemented with 
10% FBS (Hyclone, Logan, UT), 10% horse serum (Invitrogen, Carlsbad, CA), 12mM 
HEPES, and 1% Pen/Strep (Invitrogen). Neon transfection system was used according to the 
manufacturer’s instruction (Invitrogen). Briefly, LDC were harvested by trypsin digestion, 
washed with calcium and magnesium free DPBS (Invitrogen) and centrifuged. One million 
cells were suspended in 120 µl of electroporation buffer (Invitrogen) containing 2 µg DNA 
of each TALEN and were electroporated at 1300 V, 30 msec, 1 pulse. Cells were transferred 
in SCM without antibiotics and plated onto collagen I coated plates. They were cultured 
with 5% CO2 and 10% O2 at 30°C for 3 days and 37°C for 2 days.
Paris et al. Page 2
Xenotransplantation. Author manuscript; available in PMC 2018 June 25.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
SURVEYOR Mutation Detection Assay (CEL I assay)
TALEN-induced mutation was detected using the Surveyor Mutation Detection kit 
(Transgenomic, Omaha, NE). At day 5 post-transfection, genomic DNA from TALEN-
treated and un-transfected cells was extracted and PCR was performed using primers AT-F1 
(5’ CCACCTTGAGACCTTCAGCAAG 3’), AT-R1 (5’ 
GGTCATTCTCCTCATTGTCCAGATG 3’). Pwo SuperYield DNA Polymerase, dNTPack 
(Roche, Indianapolis, IN) was used and PCR conditions were as follows: 94°C, 2 minutes; 
94°C, 15 seconds, 60°C, 30 seconds and 72°C, 50 seconds for 15 cycles; 94°C, 15 seconds, 
60°C, 30 seconds and 72°C, 50 seconds with 5 seconds added to each elongation for 25 
cycles; and a final extension step of 72°C for 5 minutes. A 334 bp of PCR product was 
produced. 200–400 ng of PCR product was denatured and annealed using the following 
program on a MyCycler (Bio-Rad): 95°C, 10 minutes; 95°C to 85°C, −2°C /second; 85°C to 
25°C, −0.1°C /second. 1 µl of enhancer and 1 µl of Nuclease S (Transgenomic, Omaha, NE) 
was added to each reaction and incubated at 42°C for 40 minutes. The product was separated 
on a 10% polyacrylamide gel and stained with SYBR Safe to assess TALEN-induced 
mutations.
Screening ASGR1 Mutant cells
TALEN-treated cells were plated at 1 cell/well in ten 96-well plates coated with collagen I 
(BD, Franklin Lakes, NJ, USA). After 14 days, single cell clones became evident. Some 
cells were harvested for mutation screening. PCR was performed with a primer pair AT-F2 
(5’ CCTCCCACACCCAAGTCTGTTC 3’) and AT-R2 (5’ TCTTCCGCTTACTCCCACGC 
3’). A 379 bp of PCR products were resolved on a 1% agarose gel and purified by QIAquick 
Gel Extraction Lit (Qiagen, Valencia, CA, USA). Primer AT-F2 was used to sequence 
TALEN-targeted ASGR1 region.
DNA Sequencing analysis of TALEN-targeted ASGR1 region in cloned fetuses and piglets
Genomic DNA from cloned fetuses and piglets was extracted using DNeasy Blood & Tissue 
Kit (Qiagen, Valencia, CA). PCR, DNA purification and sequencing were performed as 
described above.
Somatic cell nuclear transfer (SCNT)
The Institutional Biosafety and Institutional Animal Care and Use Committee of the Indiana 
University School of Medicine approved animals used in this study, and housing facilities 
are AAALAC accredited. SCNT was performed using in vitro matured oocytes (DeSoto 
Biosciences Inc, St. Seymour, TN.). Cumulus cells were removed from the oocytes by 
pipetting in 0.1% hyaluronidase. Only oocytes with normal morphology and a visible polar 
body were selected for SCNT. Oocytes were incubated in manipulation media (Ca-free 
NCSU-23 with 5% FBS) containing 5 mg/mL bisbenzimide and 7.5 mg/mL cytochalasin B 
for 15 min. Oocytes were enucleated by removing the first polar body plus metaphase II 
plate, and one cell was injected into each enucleated oocyte. Couples were fused by two DC 
pulses of 140V for 50 µsec (BTX cell electroporator, Harvard Apparatus, Holliston, MA, 
USA) in 280mM mannitol, 0.001mM CaCl2, and 0.05mM MgCl2. One hour later, 
reconstructed oocytes were activated by two DC pulses of 120V for 60 µsec in 280mM 
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mannitol, 0.1mM CaCl2, and 0.05mM MgCl2 [18]. After activation, oocytes were placed 
back in NCSU-23 medium with 0.4% bovine serum albumin (BSA) and cultured at 38.5 °C, 
5% CO2 in a humidified atmosphere for less than 1 h, before being transferred into the 
recipient. Recipients were synchronized occidental gilts on their first day of estrus. Adult 
liver-derived cells (LDC) genetically modified were used to produce the ASGR1 knock out 
fetuses by SCNT. Pregnancy was interrupted at day 32 of gestation for fetus collection. 
Samples from fetuses were taken for genotype analysis. Fetal fibroblasts from collected 
fetuses were cultured and used to produce ASGR1−/− pigs by SCNT.
Liver sources
Livers were obtained as previously described from an abattoir (domestic) or from genetically 
modified pigs [3–5, 15]. Porcine livers were flushed with saline and cold Histidine-
Tryptophan-Ketoglutarate (HTK) (Essential Pharmaceuticals, Newtown, PA) preservation 
solution or cold HTK only.
Confocal analysis of ASGR1 knockout pig tissue
Frozen tissue sections (8µm) from pig liver biopsies were fixed in 4% freshly prepared 
paraformaldehyde and blocked in 2 % IgG-free BSA in HBSS for 2 hours at room 
temperature. Tissue sections were labeled with anti-ASGR1 antibody (Genway Biotech Inc., 
San Diego, CA) followed by detection with anti-rabbit secondary antibody conjugated to 
DyLight 649 (Jackson Immunoresearch, West Grove, PA). Nuclei were stained with DAPI 
(Invitrogen, Grand Island, NY) and tissue sections were washed three times with HBSS and 
mounted with Prolong Gold (n=2)(Invitrogen, Grand Island, NY). Confocal settings were 
determined by comparison to control tissue sections that received isotype control antibody.
Western blot analysis of ASGR1−/− pig liver tissue
Liver tissue was collected from domestic or ASGR1 knockout pigs and frozen at −80°C. 
Liver tissue (5.0mg) was homogenized in ice-cold RIPA lysis buffer. Proteins from lysates 
were separated on a 4–20% TGX Criterion (Bio-Rad) by SDS PAGE and transferred to 
PVDF membrane. Membranes were probed with anti-ASGR-1 (GWB-1C1B16 Genway 
Biotech INC) and anti-GAPDH (Millipore). Secondary antibodies used were donkey anti-
rabbit 800 and donkey anti-mouse 680 (LI-COR) and visualized using the LI-COR Odyssey 
scanner.
DNA sequence analysis
Total RNA was purified using the RNeasy Plus Mini Kit (Qiagen, Valencia, CA). RNA 
samples were reverse transcribed into cDNA using OneStep RT-PCR Kit (Qiagen, Valencia, 
CA) following manufacturer’s protocol. All PCR products were electrophoresed in 1% 
agarose gel and purified by QIaquick Gel Extraction Kit (Qiagen, Valencia, CA). Purified 
PCR products were ligated into the pCR4-TOPO TA plasmid vector and transformed into 
the TOP10 One Shot chemically competent bacterial cells using the TOPO TA PCR Cloning 
Kit for Sequencing (Invitrogen, Carlsbad, CA). Transformed bacteria were plated onto 
Luria–Bertani agar containing 50 µg/ml Kanamycin for clone selection. Plasmids were 
isolated using the QIAprep Spin Miniprep Kit (Qiagen, Valencia, CA, USA). Nucleotide 
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sequences were performed by the Sanger method using custom sequencing service (Core 
Facility at IUPUI).
Platelet sources, and isolation
Platelets were purchased from the Indiana Blood Bank. Platelets were counted and 
concentration adjusted to 1×1010/L in modified Krebs solution 2.0 g/L D-glucose, 0.141g/L 
MgSO4, 0.16 g/L KH2PO4, 0.35g/L KCl, 6.9 g/L NaCl, 2.10 g NaHCO3, 2.38g/L HEPES, 1 
U/mL Heparin (Sagent Pharmaceuticals, Schaumburg, IL) pH 7.2–7.4.
ex vivo perfusion
Porcine livers were removed from cold preservation and fitted with cannulas at the portal 
vein, hepatic artery, and suprahepatic inferior vena cava. The liver was placed in the 
perfusion apparatus, and the portal vein was connected to a centrifugal blood pump (Ismatec 
SA, Glattbrugg, Switzerland) and the hepatic artery to a pulsatile pump (Harvard Apparatus, 
Holliston, MA, USA). The average hepatic artery pressure was maintained manually at 60–
80 mmHg by adjusting the flow rate. The portal circuit was set to constant pressure (9 mm 
Hg) with variable flow based on feedback from a pressure meter (Hugo Sachs Elektronik-
Harvard Apparatus GmbH, March-Hugstetten, Germany). A water-jacketed hollow-fiber, 
oxygenator (Capiox® RX25, Terumo) was used. Livers were perfused for 15–20 minutes 
with 5 L warmed modified Krebs solution (described above) supplemented with 50 U/mL 
Penicillin/50µg Streptomycin (Gibco, Grand Island, NY), 0.1U/L Humulin® R (Lilly, 
Indianapolis, IN). A 2 liter water-jacketed reservoir was maintained in the circuit to facilitate 
addition of material to the system. This reservoir had a stir bar to facilitate mixing. Fifty mL 
packed washed autologous swine RBC were added to the reservior. After perfusion for 
another 15–20 minutes platelets were added. Typical flow rates were approximately 600mls 
per minute. Samples were taken from the reservoir at indicated times. Platelets were counted 
and total platelet number calculated at each time point. Platelet uptake in wild type versus 
ASGR1 deficient livers was compared using 2-factor ANOVA with repeated measures and 
platelets remaining at each time point were compared using the Holm-Sidak multiple 
comparison test using Graph Pad Prism 6.0 software.
Results
Evaluation of TALEN activity in porcine LDCs and generation of ASGR1−/− cells
TALEN transfected and non-transfected porcine LDCs were cultured at 30°C for 3 days 
followed by 37°C for 2 days [16, 17]. To evaluate the success of initial transfection and 
determine what percent of cells had a mutated ASGR1 gene, genomic DNA from transfected 
(TALEN) and non-transfected (control) cells was extracted and used in the Surveyor assay. 
The Surveyor assay examines the TALEN-induced mutagenesis efficiency. PCR products 
were hybridized to generate mismatches in heteroduplexed DNA that was then treated and 
cleaved by the SURVEYOR nuclease. Our results demonstrated that TALEN pair cleavage 
efficiency was 5.8% for a mutation in the ASGR1 coding region (Figure 2A).
Clones were isolated using single cell populations in 96 well plates. A total of 112 clones 
were screened of which eight clones were ASGR1 mutants. A single clone having a 26 bp 
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deletion that included the ASGR1 start codon was selected as a nuclear donor for SCNT 
(Figure 2B). Both alleles of the ASGR1 are likely identically mutated as this analysis 
revealed only the single mutated sequence.
Production of ASGR1 knockout fetuses and piglets by SCNT
Embryos made with cloned ASGR1−/− LDC were transferred into two gilts resulting in one 
pregnancy (Table 1). Six fetuses from this gilt were collected at day 32 of gestation. Five of 
six fetuses were well developed. Fibroblasts derived from these fetuses were used to produce 
ASGR1−/− pigs by SCNT. Four of six gilts transferred with the isolated fetal cells became 
pregnant; three of them went to term and delivered 22 piglets. One aborted at day 30 post 
embryo transfer (Table 1). Two of the piglets developed foreleg issues and were euthanized. 
Sequence analysis of genomic DNA indicated that the mutation in ASGR1 eliminated 26 
bases containing the start codon (ATG) and surrounding sequences (Figure 2B). Western 
blotting and confocal microscopy verified that animals containing this mutation did not 
express ASGR1 protein in their livers (Figures 2C and 2D).
Analysis of xenogeneic human platelet uptake by ASGR1−/− livers and liver cells
The perfusion circuit used to pass fluorescent human platelets through pig livers is shown in 
figure 3. The circuit was designed to measure platelet disappearance in the reservoir as an 
indicator of platelet consumption by the organ (Figure 3). The means and standard 
deviations for N=3 (control and ASGR1−/− livers) are shown in Figure 4. Platelet 
disappearance from the circuit was analyzed using a two-factor ANOVA with repeated 
measures (Table 2). Platelet loss from the perfusion circuit was significantly reduced in the 
presence of ASGR1 deficient livers vs. wild type livers (Table 2 row labeled Liver, 
p=0.02110). In addition, the Holm-Sidak’s multiple-comparison test revealed that, except for 
time 0, remaining platelets at each time point were different in wild type and ASGR1−/− 
circuits (p-values less than 0.05 at each timepoint). Platelets rapidly disappeared from both 
circuits within the first ten minutes of addition, though wild type livers eliminated more 
platelets during this initial phase than the ASGR1−/− organs. Dilution also contributes to this 
rapid depletion because the platelets are added to a 2-liter reservoir and are diluted by 3 
additional liters of platelet-deficient buffer residing in the remainder of the perfusion 
apparatus at time zero. Given the flow rate of approximately 600mls/min, 9 minutes were 
required to ensure platelets were present throughout the circuit, closely matching the time 
when dilution of platelets in the reservoir slowed markedly. Beyond one hour, consumption 
of platelets by the WT liver appeared to be nearly complete. Notably, even with prolonged 
time, 2 hours, the ASGR1-deficient livers did not achieve the same the amount of platelet 
consumption seen in the WT livers.
Discussion
The thrombocytopenia following graft reperfusion is a barrier to the application of liver 
xenotransplantation [1, 4, 6]. Because pig ASGR, MAC-1, and VWF have been implicated 
as mediators of the binding of human or baboon platelets to porcine LSEC and Kupffer cells, 
inactivation or modification of these molecules could reduce this barrier [4, 6]. The ASGR1 
gene was disrupted in LDC using a single transfection with TALENS, and ASGR1 knock 
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out pigs were created using SCNT of ASGR1 deficient LDCs. Off-target effects have not 
been examined in ASGR1 knock out pigs, but 17 of 19 pigs were healthy with no signs of 
illness. Knocking out the ASGR1 gene does not affect animal viability as demonstrated by 
the percentage of piglets born alive (86%) and the percentage of piglets weaned (94.7%). 
Two pigs developed foreleg problems that lead to early euthanasia; one was one day old and 
the second was 5 weeks old.
ASGR has been implicated in the clearance of platelets from circulation to lessen the 
severity of coagulopathy during sepsis, and also in the removal of platelets that have been 
cold stored [8, 10, 11, 18]. A stable complex of ASGR1 and ASGR2 in a 2:1 ratio binds 
Galβ oligosaccharides. Expression of ASGR1 and ASGR2 is necessary for a functional 
trimer [13]. Targeted deletion of ASGR1 in mice decreased platelet phagocytosis by the 
liver, exacerbating the lethal thrombosis associated with sepsis [11]. We show that disruption 
of swine ASGR1 also reduces the loss of human platelets in a normothermic ex vivo 
perfusion system.
Reduced consumption by ASGR1-deficient swine livers confirms previous experiments 
linking this receptor to the destruction of human platelets [3–5]. We have previously seen 
that blocking of ASGR with either antibodies or asialofetuin, or reducing ASGR1 abundance 
with siRNA, diminishes the uptake of human platelets by swine liver endothelial cells [5]. 
Inhibition by asialofetuin, a molecule containing carbohydrate ligands of ASGR, suggests 
that the destruction of human platelets by the swine liver is not the consequence of a species-
specific incompatibility resulting in abnormal function of swine ASGR. The half-life of 
human platelets may be affected by ASGR1 simply because when compared to pigs, human 
platelets contain increased amounts of the proposed ASGR ligands β1–4, N-acetyl 
glucosamine and galactose β1–4, N-acetyl glucosamine [15].
Though inactivation of ASGR1 is a promising first step in eliminating xenotransplant-
associated thrombocytopenia, ASGR1-deficient pig livers continued to consume human 
platelets. Additional modifications are likely necessary to eliminate the destruction of human 
platelets by the porcine livers. Other receptors such as the CD18 receptor that have been 
implicated in this process are attractive candidates to pursue [5].
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Abbreviations
ASGR asialoglycoprotein receptor
ASGR1 asialoglycoprotein receptor 1 gene
ASGR1 asialoglycoprotein receptor 1 protein
RME receptor-mediated endocytosis
VWF von Willebrand factor
SCNT somatic cell nuclear transfer
ZFN Zinc Finger Nucleases
NHEJ non-homologous end joining
TALENS Transcription activator-like effector nucleases
LDC liver-derived cells
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Figure 1. 
Model of ASGR-mediated clearance of human versus pig platelets.
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Figure 2. 
Analysis of ASGR1 disruption. Surveyor mutation detection assay examining TALEN 
activity in LDCs. (A) A 334 bp PCR product was cleaved into two fragments: 283 bp and 51 
bp. (B) DNA sequence of the ASGR1 region in a mutated single clone. The letters in red are 
where the double-strand break was created and the black letters that flank this site represent 
the TALEN binding sequences. Base deletion is shown as red dashes. (C) Immuno-blot 
examination of whole liver tissue lysates from wild type and ASGR1−/− pigs. ASGR1 is the 
green band and the loading control protein GAPDH is in red. (D) Porcine frozen tissue 
sections were fixed and labeled with anti-CD31 and anti-ASGR1 antibodies, detected with 
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fluorescently conjugated secondary antibodies and analyzed by confocal microscopy. 
Domestic pig liver samples were positive for CD31 (magenta) and ASGR1 (yellow). 
ASGR1−/− pig liver tissue expressed CD31 but was negative for ASGR1. Image intensity 
was determined by comparison to the isotype control.
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Figure 3. 
Diagram of the perfusion circuit setup.
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Figure 4. 
Examination of human platelet loss when perfused through pig livers. Platelet loss from 
perfusion circuits containing either ASGR1−/− or WT livers is compared. Means and 
standard deviations are shown (N=3 animals for each group).
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